GECO: gene expression correlation analysis after genetic algorithm-driven deconvolution
Authors:
- 13 July 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (1) , 156-159
Abstract
Large-scale gene expression analysis is a valuable asset for data-driven hypothesis generation. However, the convoluted nature of large expression datasets often hinders extraction of meaningful biological information. To this end, we developed GECO, a gene expression correlation analysis software that uses a genetic algorithm-driven approach to deconvolute complex expression datasets into two subpopulations that display positive and negative correlations between a pair of queried genes. GECO’s mutational enrichment and pairwise drug sensitivity analyses functions that follow the deconvolution step may help to identify the mutational factors that drive the gene expression correlation in the generated subpopulations and their differential drug vulnerabilities. Finally, GECO’s drug sensitivity screen function can be used to identify drugs that differentially affect the subpopulations. http://www.proteinguru.com/geco/ and http://www.proteinguru.com/geco/codes/ Supplementary data are available at Bioinformatics online.Keywords
This publication has 18 references indexed in Scilit:
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsNucleic Acids Research, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Circumventing Cancer Drug Resistance in the Era of Personalized MedicineCancer Discovery, 2012
- Inhibitor of PI3Kγ ameliorates TNBS‐induced colitis in mice by affecting the functional activity of CD4+CD25+FoxP3+ regulatory T cellsBritish Journal of Pharmacology, 2011
- A phosphoinositide 3-kinase-γ inhibitor, AS605240 prevents bleomycin-induced pulmonary fibrosis in ratsBiochemical and Biophysical Research Communications, 2010
- R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapyCell Death & Differentiation, 2007
- Recruitment of insulin receptor substrate-1 and activation of NF-κB essential for midkine growth signaling through anaplastic lymphoma kinaseOncogene, 2006
- BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in MiceJournal of Biological Chemistry, 2003
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999